PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Pacific Biosciences Of California, Inc. Return On Equity for the quarter ending September 30, 2024 was -68.7 %, a 47.8% decline year-over-year.
  • Pacific Biosciences Of California, Inc. annual Return On Equity for 2023 was -43.8 %, a 9.12% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Return On Equity for 2022 was -48.2 %, a 44.4% decline from 2021.
  • Pacific Biosciences Of California, Inc. annual Return On Equity for 2021 was -33.4 %, a 261% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -43.8 +4.4 +9.12% Jan 1, 2023 Dec 31, 2023
2022 -48.2 -14.8 -44.4% Jan 1, 2022 Dec 31, 2022
2021 -33.4 -54.2 -261% Jan 1, 2021 Dec 31, 2021
2020 20.8 +142 Jan 1, 2020 Dec 31, 2020
2019 -122 -27.2 -28.8% Jan 1, 2019 Dec 31, 2019
2018 -94.5 +4.49 +4.54% Jan 1, 2018 Dec 31, 2018
2017 -99 -20.7 -26.5% Jan 1, 2017 Dec 31, 2017
2016 -78.3 -11.3 -16.8% Jan 1, 2016 Dec 31, 2016
2015 -67 +42.1 +38.6% Jan 1, 2015 Dec 31, 2015
2014 -109 -21.1 -23.9% Jan 1, 2014 Dec 31, 2014
2013 -88.1 -19.9 -29.1% Jan 1, 2013 Dec 31, 2013
2012 -68.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.